TapewireFind a company

person · Reporting owner

Miller Steven D

Disclosed activity across 6 companies

Tapewire entity
61336
SEC CIK
0001844277

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
Bausch Health Companies Inc.BHC · Entity 4363DirectorMay 16, 2025May 20, 2025
CONDUENT IncCNDT · Entity 1191DirectorJanuary 15, 2024January 16, 2024
DANA IncDAN · Entity 6DirectorNovember 29, 2024December 02, 2024
HERC HOLDINGS INCHRI · Entity 3949DirectorMay 12, 2022May 16, 2022
JETBLUE AIRWAYS CORPJBLU · Entity 808DirectorMarch 10, 2026March 13, 2026
Xerox Holdings CorpXRX · Entity 5610DirectorMay 25, 2023May 31, 2023

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

Bausch Health Companies Inc.

Report date May 16, 2025 · Filed May 20, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common Shares, No Par ValueSEC Table I · non-derivativeDirect229,224 Reported balance After 2025-05-16 transaction · row 1
1 source row

Row 1 · 2025-05-16 · Grant · Acquired 54,347 · Balance 229,224

F1: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Common Shares, No Par ValueSEC Table I · non-derivativeIndirectBy IRA10,000 Reported balance Holding disclosure · report date 2025-05-16 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 10,000

Filing footnotes · ownership attribution and instrument terms

F1: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

CONDUENT Inc

Report date January 15, 2024 · Filed January 16, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect162,163 Reported balance After 2024-01-15 transaction · row 1
1 source row

Row 1 · 2024-01-15 · Grant · Acquired 53,522 · Balance 162,163

F1: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director.

Filing footnotes · ownership attribution and instrument terms

F1: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director.

DANA Inc

Report date November 29, 2024 · Filed December 02, 2024

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect425 Reported balance After 2024-11-29 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2024-11-29 · Grant · Acquired 126 · Balance 425

F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Filing footnotes · ownership attribution and instrument terms

F1: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

HERC HOLDINGS INC

Report date May 12, 2022 · Filed May 16, 2022

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Phantom StockSEC Table II · derivative / convertible securityDirect1,101 Reported balance After 2022-05-12 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2022-05-12 · Grant · Acquired 1,101 · Balance 1,101

F1: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock.

F2: The value of the phantom stock credited to the Reporting Person's account shall be distributed in shares of common stock following the date the Reporting Person ceases to be a member of the Issuer's Board of Directors, provided that the event occurs on or after the date of the Issuer's 2023 annual meeting of stockholders (or, if earlier following a change of control).

Filing footnotes · ownership attribution and instrument terms

F1: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock.

F2: The value of the phantom stock credited to the Reporting Person's account shall be distributed in shares of common stock following the date the Reporting Person ceases to be a member of the Issuer's Board of Directors, provided that the event occurs on or after the date of the Issuer's 2023 annual meeting of stockholders (or, if earlier following a change of control).

JETBLUE AIRWAYS CORP

Report date March 10, 2026 · Filed March 13, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect22,094 Reported balance After 2026-03-10 transaction · row 1
1 source row

Row 1 · 2026-03-10 · Exercise / conversion · Acquired 22,094 · Balance 22,094

F1: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

Deferred Stock UnitsSEC Table II · derivative / convertible securityDirect59,483 Reported balance After 2026-03-10 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-03-10 · Grant · Acquired 29,867 · Balance 59,483

F2: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F3: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2026.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect0 Reported balance After 2026-03-10 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-03-10 · Exercise / conversion · Disposed 22,094 · Balance 0

F1: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F4: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

Filing footnotes · ownership attribution and instrument terms

F1: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F2: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F3: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2026.

F4: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

Xerox Holdings Corp

Report date May 25, 2023 · Filed May 31, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Deferred Stock UnitsSEC Table I · non-derivativeDirect55,966 Reported balance After 2023-05-25 transaction · row 1 Account or security details depend on footnotes; rows are not merged.
1 source row

Row 1 · 2023-05-25 · Grant · Acquired 22,561 · Balance 55,966

F1: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director or death, subject to any applicable deferral period.

F2: These DSUs will vest on May 25, 2024.

F3: Balance adjusted to reflect 529 DSUs awarded June 30, 2022; 593 DSUs awarded September 30, 2022; 559 DSUs awarded December 31, 2022; and 543 DSUs awarded March 31, 2023 from dividend equivalents attributable to DSUs held as of the relevant record dates.

Filing footnotes · ownership attribution and instrument terms

F1: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director or death, subject to any applicable deferral period.

F2: These DSUs will vest on May 25, 2024.

F3: Balance adjusted to reflect 529 DSUs awarded June 30, 2022; 593 DSUs awarded September 30, 2022; 559 DSUs awarded December 31, 2022; and 543 DSUs awarded March 31, 2023 from dividend equivalents attributable to DSUs held as of the relevant record dates.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
March 10, 2026 Filed Mar 13, 2026 01:25 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 Exercise / conversionRestricted Stock Units · Derivative 22,094 Not disclosed Not disclosed
Disclosure

SEC source: 0001158463-26-000015 · wk-form4_1773365141.xml · derivative · entry 3

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 22,094 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F1 · price: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F4 · derivative.exercise_date: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

F4 · derivative.expiration_date: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 01:25 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 GrantDeferred Stock Units · Derivative 29,867 Not disclosed Not disclosed
Disclosure

SEC source: 0001158463-26-000015 · wk-form4_1773365141.xml · derivative · entry 2

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,483

Underlying: Common Stock · 29,867 shares

Expires not disclosed

F2 · derivative.exercise_price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F2 · price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F3 · derivative.exercise_date: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2026.

F3 · derivative.expiration_date: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2026.

Read SEC document
March 10, 2026 Filed Mar 13, 2026 01:25 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 Exercise / conversionCommon Stock 22,094 Not disclosed Not disclosed
Disclosure

SEC source: 0001158463-26-000015 · wk-form4_1773365141.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,094

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

Read SEC document
May 16, 2025 Filed May 20, 2025 20:31 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 54,347 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-015027 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 229,224

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 10, 2025 Filed Mar 13, 2025 00:40 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 GrantDeferred Stock Units · Derivative 22,094 Not disclosed Not disclosed
Disclosure

SEC source: 0001158463-25-000034 · wk-form4_1741826393.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 51,710

Underlying: Common Stock · 22,094 shares

Expires not disclosed

F1 · derivative.exercise_price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F1 · price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors. The annual DSU grant vests on the one year anniversary of the grant date.

F2 · derivative.exercise_date: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2025.

F2 · derivative.expiration_date: The award subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of March 10, 2025.

Read SEC document
March 10, 2025 Filed Dec 29, 2025 22:15 UTC Amendment JETBLUE AIRWAYS CORP JBLU · Entity 808 GrantRestricted Stock Units · Derivative 22,094 Not disclosed Not disclosed
Disclosure

SEC source: 0001158463-25-000124 · wk-form4a_1767046547.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,094

Underlying: Common Stock · 22,094 shares

Expires not disclosed

F1 · derivative.exercise_price: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F1 · price: Upon vesting, the Reporting Person is entitled to receive one share of common stock for each restricted stock unit.

F2 · derivative.exercise_date: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

F2 · derivative.expiration_date: The director restricted stock units vest on the one year anniversary of the grant date of March 10, 2025.

Read SEC document
November 29, 2024 Filed Dec 2, 2024 21:35 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 126 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-010319 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 425

Underlying: Common Stock, par value $0.01 · 126 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
August 30, 2024 Filed Sep 4, 2024 20:40 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 111 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-008466 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 299

Underlying: Common Stock, par value $0.01 · 111 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
June 22, 2024 Filed Jun 25, 2024 21:44 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 GrantDeferred Stock Units · Derivative 6,097 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-24-000578 · ownership.xml · derivative · entry 2

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,616

Underlying: Common Stock · 6,097 shares

Expires not disclosed

F1 · derivative.exercise_price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors.

F1 · price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors.

F3 · derivative.exercise_date: The shares subject to the DSUs are scheduled to vest equally over three years, measured from the vesting commencement date of June 22, 2024.

F3 · derivative.expiration_date: The shares subject to the DSUs are scheduled to vest equally over three years, measured from the vesting commencement date of June 22, 2024.

Read SEC document
June 22, 2024 Filed Jun 25, 2024 21:44 UTC JETBLUE AIRWAYS CORP JBLU · Entity 808 GrantDeferred Stock Units · Derivative 23,519 Not disclosed Not disclosed
Disclosure

SEC source: 0000947871-24-000578 · ownership.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,519

Underlying: Common Stock · 23,519 shares

Expires not disclosed

F1 · derivative.exercise_price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors.

F1 · price: This represents an award of deferred stock units, or DSUs. Each unit entitles the Reporting Person to one share of Issuer's common stock upon vesting; settlement of vested DSUs will occur six months following Reporting Person's departure from Issuer's Board of Directors.

F2 · derivative.exercise_date: The shares subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of June 22, 2024.

F2 · derivative.expiration_date: The shares subject to the DSUs are scheduled to vest over one year, measured from the vesting commencement date of June 22, 2024.

Read SEC document
May 31, 2024 Filed Jun 4, 2024 20:44 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 88 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-006579 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188

Underlying: Common Stock, par value $0.01 · 88 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
May 17, 2024 Filed May 20, 2024 21:49 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 35,360 $0.00 $0.00
Disclosure

SEC source: 0001127602-24-016030 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 174,877

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 22, 2024 Filed Mar 26, 2024 20:37 UTC DANA Inc DAN · Entity 6 GrantDividend Equivalent Rights · Derivative 100 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-004524 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100

Underlying: Common Stock, par value $0.01 · 100 shares

Expires not disclosed

F1 · derivative.exercise_price: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.exercise_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

F1 · derivative.expiration_date: Dividend equivalent rights accrued on previously granted restricted stock units and become exercisable proportionately with the restricted stock units to which they relate. Each dividend equivalent right is the economic equivalent of one share of Dana common stock.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:15 UTC DANA Inc DAN · Entity 6 Exercise / conversionRestricted Stock Units · Derivative 2,886 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002482 · doc4.xml · derivative · entry 2

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock, par value $0.01 · 2,886 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F2 · derivative.exercise_date: Restricted stock units previously granted vested in full on February 15, 2024.

F2 · derivative.expiration_date: Restricted stock units previously granted vested in full on February 15, 2024.

Read SEC document
February 15, 2024 Filed Feb 20, 2024 22:15 UTC DANA Inc DAN · Entity 6 Exercise / conversionCommon Stock, par value $0.01 2,886 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002482 · doc4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,886

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
February 14, 2024 Filed Feb 15, 2024 22:32 UTC DANA Inc DAN · Entity 6 GrantRestricted Stock Units · Derivative 12,359 $0.00 $0.00
Disclosure

SEC source: 0001225208-24-002204 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 12,359

Underlying: Common Stock, par value $0.01 · 12,359 shares

Expires not disclosed

F1 · security: Restricted stock units granted pursuant to the Dana Incorporated 2021 Omnibus Incentive Plan.

F2 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F3 · derivative.exercise_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

F3 · derivative.expiration_date: Restricted stock units granted vest in full on the first anniversary date of the grant.

Read SEC document
January 15, 2024 Filed Jan 16, 2024 21:39 UTC CONDUENT Inc CNDT · Entity 1191 GrantCommon Stock 53,522 $3.55 $190,003.10
Disclosure

SEC source: 0001677703-24-000024 · wk-form4_1705441175.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 162,163

F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director.

Read SEC document
December 12, 2023 Filed Dec 13, 2023 21:55 UTC DANA Inc DAN · Entity 6 GrantRestricted Stock Units · Derivative 2,886 $0.00 $0.00
Disclosure

SEC source: 0001225208-23-011061 · doc4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,886

Underlying: Common Stock, par value $0.01 · 2,886 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit granted represents the right to receive one share of Dana common stock or, at the election of Dana, cash equal to the market value per share. Each restricted stock unit contains dividend equivalent rights.

F2 · derivative.exercise_date: Restricted stock units granted vest in full on February 15, 2024.

F2 · derivative.expiration_date: Restricted stock units granted vest in full on February 15, 2024.

Read SEC document
May 25, 2023 Filed May 31, 2023 19:10 UTC Xerox Holdings Corp XRX · Entity 5610 GrantDeferred Stock Units 22,561 $0.00 $0.00
Disclosure

SEC source: 0000899243-23-014163 · doc4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 55,966

F1 · security: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director or death, subject to any applicable deferral period.

F2 · shares: These DSUs will vest on May 25, 2024.

F3 · balance_after: Balance adjusted to reflect 529 DSUs awarded June 30, 2022; 593 DSUs awarded September 30, 2022; 559 DSUs awarded December 31, 2022; and 543 DSUs awarded March 31, 2023 from dividend equivalents attributable to DSUs held as of the relevant record dates.

Read SEC document
May 19, 2023 Filed May 19, 2023 20:14 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 29,205 $0.00 $0.00
Disclosure

SEC source: 0001127602-23-016288 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 139,517

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
January 15, 2023 Filed Jan 18, 2023 21:59 UTC CONDUENT Inc CNDT · Entity 1191 GrantCommon Stock 40,861 $4.65 $190,003.65
Disclosure

SEC source: 0001127602-23-001662 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 108,641

F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director.

Read SEC document
December 30, 2022 Filed Jan 3, 2023 22:07 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,589 $6.28 $28,818.92
Disclosure

SEC source: 0001127602-23-000169 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 110,312

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
September 30, 2022 Filed Oct 3, 2022 20:45 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 4,444 $6.89 $30,619.16
Disclosure

SEC source: 0001127602-22-023265 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 105,723

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 30, 2022 Filed Jul 5, 2022 22:01 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 3,663 $8.36 $30,622.68
Disclosure

SEC source: 0001127602-22-018804 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 101,279

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 24, 2022 Filed Jun 28, 2022 20:52 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 34,387 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-018210 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 97,616

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
May 19, 2022 Filed May 23, 2022 14:06 UTC Xerox Holdings Corp XRX · Entity 5610 GrantDeferred Stock Units 17,951 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-015340 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,181

F1 · security: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director, subject to any applicable deferral period.

F2 · shares: These DSUs will vest on May 19, 2023.

F3 · balance_after: Balance has been adjusted to reflect 161 DSUs awarded March 31, 2022 from reinvestment of dividend equivalents attributable to DSUs held as of the relevant record dates.

Read SEC document
May 12, 2022 Filed May 16, 2022 20:57 UTC HERC HOLDINGS INC HRI · Entity 3949 GrantPhantom Stock · Derivative 1,101 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-014663 · form4.xml · derivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101

Underlying: Common Stock · 1,101 shares

Expires not disclosed

F1 · derivative.exercise_price: Each share of phantom stock is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: The value of the phantom stock credited to the Reporting Person's account shall be distributed in shares of common stock following the date the Reporting Person ceases to be a member of the Issuer's Board of Directors, provided that the event occurs on or after the date of the Issuer's 2023 annual meeting of stockholders (or, if earlier following a change of control).

F2 · derivative.expiration_date: The value of the phantom stock credited to the Reporting Person's account shall be distributed in shares of common stock following the date the Reporting Person ceases to be a member of the Issuer's Board of Directors, provided that the event occurs on or after the date of the Issuer's 2023 annual meeting of stockholders (or, if earlier following a change of control).

Read SEC document
March 31, 2022 Filed Apr 4, 2022 22:04 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 1,340 $22.85 $30,619.00
Disclosure

SEC source: 0001127602-22-011296 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,229

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
February 17, 2022 Filed Feb 22, 2022 20:14 UTC Xerox Holdings Corp XRX · Entity 5610 GrantDeferred Stock Units 222 $0.00 $0.00
Disclosure

SEC source: 0001127602-22-005968 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,069

F1 · security: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director, subject to any applicable deferral period.

F2 · balance_after: Balance adjusted to reflect 133 DSUs awarded June 30, 2021; 155 DSUs awarded September 30, 2021; and 140 DSUs awarded December 31, 2021 from reinvestment of dividend equivalents attributable to DSUs held as of the relevant record dates.

Read SEC document
January 15, 2022 Filed Jan 19, 2022 22:17 UTC CONDUENT Inc CNDT · Entity 1191 GrantCommon Stock 33,629 $5.65 $190,003.85
Disclosure

SEC source: 0001677703-22-000005 · primary_doc.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 67,780

F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock upon separation of service as a director.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 21:10 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 1,109 $27.61 $30,619.49
Disclosure

SEC source: 0001127602-22-000092 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,889

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
November 30, 2021 Filed Dec 3, 2021 00:15 UTC Bausch Health Companies Inc. BHC · Entity 4363 PurchaseCommon Shares, No Par Value 10,000 $24.17 $241,699.00
Disclosure

SEC source: 0001127602-21-030159 · form4.xml · nonDerivative · entry 2

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By IRA

Disclosed balance after: 10,000

Read SEC document
November 30, 2021 Filed Dec 3, 2021 00:15 UTC Bausch Health Companies Inc. BHC · Entity 4363 PurchaseCommon Shares, No Par Value 50,000 $24.24 $1,211,825.00
Disclosure

SEC source: 0001127602-21-030159 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 60,780

Read SEC document
September 30, 2021 Filed Oct 4, 2021 20:44 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 1,099 $27.85 $30,607.15
Disclosure

SEC source: 0001127602-21-026453 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,780

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
June 30, 2021 Filed Jul 2, 2021 20:11 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 1,044 $29.32 $30,610.08
Disclosure

SEC source: 0001127602-21-021220 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,681

F1 · shares: Reflects Restricted Share Units, each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
May 20, 2021 Filed May 24, 2021 20:30 UTC Xerox Holdings Corp XRX · Entity 5610 GrantDeferred Stock Units 12,950 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-017901 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,950

F1 · security: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director. DSUs vest one year after the May 20, 2021 award date.

Read SEC document
May 20, 2021 Filed Jun 4, 2021 21:40 UTC Amendment Xerox Holdings Corp XRX · Entity 5610 GrantDeferred Stock Units 12,419 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-019297 · form4a.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,419

F1 · security: Each Deferred Stock Unit (DSU) represents the right to receive one share of common stock upon the reporting person's termination of service as a director. DSUs vest one year after the May 20, 2021 award date.

F2 · shares: On May 24, 2021, the reporting person filed a Form 4 reporting the acquisition of DSUs ("Original Form 4"). This amendment is being filed solely to correct the number of shares reported in column 4 of the Original Form 4, as well as the number of securities beneficially owned following the transaction as reported in column 5 of the Original Form 4.

F2 · balance_after: On May 24, 2021, the reporting person filed a Form 4 reporting the acquisition of DSUs ("Original Form 4"). This amendment is being filed solely to correct the number of shares reported in column 4 of the Original Form 4, as well as the number of securities beneficially owned following the transaction as reported in column 5 of the Original Form 4.

Read SEC document
April 30, 2021 Filed May 3, 2021 20:08 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 7,645 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-014910 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,637

F1 · shares: Represents the award of restricted share units ("RSUs") granted to non-employee directors of the Issuer on the third business day following their election at the Issuer's Annual Meeting of Shareholders. The RSUs have a grant date value equal to $250,000, vest immediately prior to the Issuer's next Annual Meeting of Shareholders, and are settled in common shares, no par value, of the Issuer.

Read SEC document
March 31, 2021 Filed Apr 2, 2021 21:11 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 148 $31.74 $4,697.52
Disclosure

SEC source: 0001127602-21-012735 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 992

F1 · shares: Reflects Restricted Share Units ("RSUs"), each representing a contingent right to receive one common share, no par value, of Bausch Health Companies Inc.

Read SEC document
March 22, 2021 Filed Mar 24, 2021 20:38 UTC Bausch Health Companies Inc. BHC · Entity 4363 GrantCommon Shares, No Par Value 744 $0.00 $0.00
Disclosure

SEC source: 0001127602-21-011920 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 844

F1 · shares: Represents Restricted Share Units ("RSUs"), each representing a contingent right to receive one Common Share, no par value, of Bausch Health Companies Inc., which will vest immediately before the 2021 Annual Meeting of Shareholders.

Read SEC document
February 03, 2021 Filed Feb 5, 2021 23:50 UTC CONDUENT Inc CNDT · Entity 1191 GrantCommon Stock 34,151 $5.10 $174,170.10
Disclosure

SEC source: 0001127602-21-004249 · form4.xml · nonDerivative · entry 1

Miller Steven D · CIK 0001844277 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,151

F1 · shares: Award of Deferred Stock Units that represent the right to receive one share of common stock on the earlier of one year following date of grant or termination of service.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.